Showing 1161-1170 of 1496 results for "".
- Hydrafacial and Glytone Team Up to Launch New Boosterhttps://modernaesthetics.com/news/hydrafacial-and-glytone-team-up-to-launch-new-booster-1/2473323/The Beauty Health Company’s Hydrafacial is rolling out a new exfoliating booster co-created with Glytone. The Glytone AHA Resurfacing Cellular Booster leverages a unique combination of three alpha hydroxy acids (AHAs) that may help improve the appearance of skin surface and textur
- Allergan Aesthetics Celebrates Fourth Annual BOTOX Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-fourth-annual-botox-cosmetic-day/2473322/Allergan Aesthetics is inviting people across the country to take a "Moment for You" on Wednesday, Nov. 16, 2022 to celebrate the biggest event of the year for Botox Cosmetic. For this year's celebration, BOTOX Cosmetic is sharing two exclusive offers availa
- FDA Clears Aesthetics Biomedical's Vivace Ultrahttps://modernaesthetics.com/news/fda-clears-aesthetics-biomedicals-vivace-ultra/2473317/The FDA has cleared Aesthetics Biomedical Inc.’s Vivace Ultra, the next generation and of personalized aesthetics, for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. An innovative reimagination and technical upgrade of the legacy Vivace
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre
- Right to Repair: How Developments Could Affect Aesthetics Practiceshttps://modernaesthetics.com/news/right-to-repair-how-developments-could-affect-aesthetics-practices/2473311/Recent action on the federal level has renewed interest in “Right to Repair” legislation, and the medical aesthetics industry is eyeing developments that might directly impact aesthetic practices and medspas. Right to Repair legislation dates back to the 1970s, and mos
- BeautyHealth’s Hydrafacial Teams Up with JLohttps://modernaesthetics.com/news/beautyhealths-hydrafacial-teams-up-with-jlo/2473309/The BeautyHealth Company is rolling out the Hydrafacial x JLo Beauty Booster. “I'm so excited to partner with Hydrafacial to create the new JLo Beauty Booster,” says founder of JLo Beauty Jennifer Lopez in a news release. “Hydrafacial is one of my favorite treatmen
- Power Move: UFC Performance Institute to Use Lutronic Accufit for Training, Rehabhttps://modernaesthetics.com/news/power-move-ufc-performance-institute-to-use-lutronic-accufit-for-training-rehab/2473308/Lutronic's Accufit will now be made available for use to UFC fighters and other elite athletes through the UFC Performance Institute. "Accufit provides a higher energy multi-dimensional muscle workout, and the body contouring iprovement is dramatic. This 3rd generation intellig
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra